1. Home
  2. EVAX vs ONFO Comparison

EVAX vs ONFO Comparison

Compare EVAX & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • ONFO
  • Stock Information
  • Founded
  • EVAX 2008
  • ONFO 2018
  • Country
  • EVAX Denmark
  • ONFO United States
  • Employees
  • EVAX N/A
  • ONFO N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • ONFO Computer Software: Programming Data Processing
  • Sector
  • EVAX Health Care
  • ONFO Technology
  • Exchange
  • EVAX Nasdaq
  • ONFO Nasdaq
  • Market Cap
  • EVAX 8.7M
  • ONFO 6.7M
  • IPO Year
  • EVAX 2021
  • ONFO 2022
  • Fundamental
  • Price
  • EVAX $2.49
  • ONFO $1.35
  • Analyst Decision
  • EVAX Strong Buy
  • ONFO
  • Analyst Count
  • EVAX 3
  • ONFO 0
  • Target Price
  • EVAX $33.33
  • ONFO N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • ONFO 11.8K
  • Earning Date
  • EVAX 03-26-2025
  • ONFO 11-15-2024
  • Dividend Yield
  • EVAX N/A
  • ONFO N/A
  • EPS Growth
  • EVAX N/A
  • ONFO N/A
  • EPS
  • EVAX N/A
  • ONFO N/A
  • Revenue
  • EVAX $3,295,000.00
  • ONFO $6,590,171.00
  • Revenue This Year
  • EVAX $9,039.73
  • ONFO $133.59
  • Revenue Next Year
  • EVAX $1.47
  • ONFO N/A
  • P/E Ratio
  • EVAX N/A
  • ONFO N/A
  • Revenue Growth
  • EVAX N/A
  • ONFO 29.25
  • 52 Week Low
  • EVAX $2.22
  • ONFO $0.39
  • 52 Week High
  • EVAX $22.50
  • ONFO $1.88
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 39.85
  • ONFO 52.87
  • Support Level
  • EVAX $2.30
  • ONFO $1.25
  • Resistance Level
  • EVAX $2.80
  • ONFO $1.47
  • Average True Range (ATR)
  • EVAX 0.51
  • ONFO 0.08
  • MACD
  • EVAX 0.03
  • ONFO 0.02
  • Stochastic Oscillator
  • EVAX 6.97
  • ONFO 53.57

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About ONFO Onfolio Holdings Inc.

Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.

Share on Social Networks: